Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
23ME-01473 for Solid Tumors
Recruiting1 awardPhase 1 & 2
San Antonio, Texas
This trial is testing a new drug called 23ME-01473 in patients with advanced solid cancers who have not responded well to standard treatments. The study aims to assess the safety, how well the
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.